Clinical trial
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
NCT04063501 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 9, 2021
- Completion date
- February 28, 2027
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer